Once-daily tenofovir disoproxil fumarate in treatment-naive Taiwanese patients with chronic hepatitis B and minimally raised alanine aminotransferase (TORCH-B): a multicentre, double-blind, placebo-controlled, parallel-group, randomised trial

Yao-Chun HsuChi-Yi ChenI-Wei ChangChi-Yang ChangChun-Ying WuTeng-Yu LeeMing-Shiang WuMing-Jong BairJyh-Jou ChenChieh-Chang ChenCheng-Hao TsengChi-Ming TaiYen-Tsung HuangWen-Hui KuLein-Ray MoJaw-Town Lin2026-01-302026-01-302021-0610.1016/S1473-3099(20)30692-7https://scholars.csmu.edu.tw/handle/123456789/4185[SDGs]SDG3Once-daily tenofovir disoproxil fumarate in treatment-naive Taiwanese patients with chronic hepatitis B and minimally raised alanine aminotransferase (TORCH-B): a multicentre, double-blind, placebo-controlled, parallel-group, randomised trialjournal-article